Below are the most recent publications written about "Analgesics, Opioid" by people in Profiles.
-
Bayly R, Cordes J, Bernson D, Ackerson LK, LaRochelle MR, Hassan GH, Bauer CX, Stopka TJ. Predicting fatal opioid-involved overdoses: A social-ecological framework matched to a linked-data warehouse. Int J Drug Policy. 2025 Mar; 137:104730.
-
Williams BR, Gamble MC, Singh N, Bryant CD, Logan BA, Logan RW. Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome. Neuroscience. 2025 Mar 17; 569:85-91.
-
Lynn T, Kelleher ME, Georges HM, McCauley EM, Logan RW, Yonkers KA, Abrahams VM. Buprenorphine induces human fetal membrane sterile inflammation. J Reprod Immunol. 2025 Mar; 168:104445.
-
Okafor IA, Mbagwu SI, Chidera IG, Augustine EC, Anagboso IM, Onyema CE. The effect of coadministration of vitamin D and tramadol on serum kisspeptin, testosterone, oxidative stress levels and testicular histology in Wistar rats: a preliminary report. Rev Int Androl. 2024 Dec; 22(4):59-67.
-
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
-
Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A. HIV-1 latency reversal agent boosting is not limited by opioid use. JCI Insight. 2024 Nov 22; 9(22).
-
Punches BE, Brown JL, Lyons MS, Gillespie GL, Boyer EW, Anderson AR, Carreiro S, Bischof JJ, Kauffman E, Young H, Spatholt D, Tan A, Donneyong M, Ni A, Bakas T. Development and Validation of the Decisions to use Opioids Measure. Pain Manag Nurs. 2025 Apr; 26(2):149-155.
-
Andraka-Christou B, Viglione J, Ahmed F, Del Pozo B, Atkins DN, Clark MH, Totaram R, Pivovarova E. Factors affecting problem-solving court team decisions about medications for opioid use disorder. J Subst Use Addict Treat. 2025 Jan; 168:209525.
-
Essien-Aleksi IE, Zhang Y, Koren A, Palacios N, Falcon LM, Tucker KL. The Mediating Effect of Depression on Perceived Discrimination and Persistent Prescription Opioid Use Among Puerto Rican Adults. J Addict Nurs. 2024 Oct-Dec 01; 35(4):171-179.
-
Babu KM, Haddad YK, Causey ST, Vargas-Torres CC, Martinez PM, Goldberg EM, Dorfman JD, Bleser JA, Chapman BP, Lai JT, Saif R, Elhoussan R, Graham LA, Krotulski AJ, Walton SE, Thomas FD, Logan BK, C Merchant R. Detection of ethanol, cannabinoids, benzodiazepines, and opioids in older adults evaluated for serious injuries from falls. Clin Toxicol (Phila). 2024 Oct; 62(10):661-668.